PBYI Stock Price Prediction 2026-2027
AI-powered forecast for Puma Biotechnology Inc
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$7.47
Price Targets for 2027
Bear Case
$4.25
-43.1%
Base Case
$5.00
-33.1%
Bull Case
$5.75
-23.0%
Prediction Tracking
Coming Soon for PBYI
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for PBYI
Key Factors Influencing PBYI Stock
Bullish Factors
- Revenue growth of 0.3% year-over-year
- Market position and competitive advantages
Risk Factors
- Bear case implies 43% downside risk
- Market volatility and macroeconomic factors
- Competitive pressures in Biotechnology
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $5.00.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for PBYI
Frequently Asked Questions
What is PBYI stock price today?
PBYI (Puma Biotechnology Inc) stock is trading at $7.47 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is PBYI stock going up or down today?
PBYI stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy PBYI stock now?
The decision to buy PBYI depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is PBYI a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for PBYI based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is PBYI stock overvalued or undervalued?
PBYI currently trades at a P/E ratio of 11.87, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if PBYI is fairly priced.
What is PBYI's P/E ratio?
PBYI has a price-to-earnings (P/E) ratio of 11.87, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is PBYI's market cap?
PBYI (Puma Biotechnology Inc) has a market capitalization of $0.37 billion, making it a small-cap stock.
What is PBYI's price to book ratio?
PBYI trades at a price-to-book (P/B) ratio of 2.92, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does PBYI pay dividends?
PBYI does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is PBYI's dividend yield?
PBYI does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is PBYI stock a good long-term investment?
PBYI's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is PBYI's revenue growth rate?
PBYI has shown revenue growth of 0.3% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is PBYI profitable?
Yes, PBYI is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.
What are the risks of investing in PBYI?
Key risks for PBYI include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does PBYI compare to its competitors?
Compare PBYI to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PBYI's performance and positioning.
What is PBYI's stock price target for 2026?
Our AI model provides price targets for PBYI based on fundamental analysis: Bull case $9.71 (+30%), Base case $8.59 (+15%), Bear case $6.72 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about PBYI?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for PBYI. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is PBYI's next earnings report?
PBYI reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.